Immuno Cure
Business Services · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
F Building 12w Hong Kong Science Park Sh...Phone Number
+852 26820299Website
www.immunocure.hkRevenue
$33.1 MillionIndustry
About Immuno Cure
Immuno Cure Org Chart
Is Immuno Cure your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Immuno Cure is spiking on competitors!
Product Launch: Get notified when Immuno Cure launches new products
Website visits: Recent activity has been detected on your website
Click to see if Immuno Cure had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Immuno Cure recently announced quarterly report
Check if Immuno Cure has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Immuno Cure has new funding data
Immuno Cure, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Immuno Cure
Recommended Actions
Find VP level buyers at Immuno Cure
Find 3 more new buyers
Company Profile Activity
Activity Insights
Immuno Cure is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Immuno Cure is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Immuno Cure.
Immuno Cure financials insights
Gather financial insights about Immuno Cure, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Grant
$1M
Series A
$12M
Immuno Cure Tech Stack
A closer look at the technologies used by Immuno Cure
Most Recent Scoops
Immuno Cure News & Media
Hong Kong-based startup Immuno Cure BioTech raises $12M in series A round
Hong Kong's Immuno Cure BioTech raises $12M in series AImmuno Cure kick off Phase I Clinical Trial in Shenzhen
A significant step for developing our PD-1-Enhanced DNA Vaccine against HIV/AIDS HONG KONG, Feb. 16, 2023 /PRNewswire/ -- Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in PD-1-Enhanced DNA vaccines and immunotherapies, announced the kicking off of the Phase I Clinical Trial of ICVAX, a therapeutic vaccine against HIV/AIDS, at The National Clinical Research Center for Infectious Diseases at The Third People's Hospital of Shenzhen. HIV-1Immuno Cure appoints new CFO
Strengthening of executive management team to propel growth strategy HONG KONG, Nov. 1, 2022 /PRNewswire/ -- Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in DNA vaccines and immunotherapies, announced today the appointment of Mr Mark LO Chun Bun as Chief Financial Officer of the Group. Mr Mark Lo has over 20 years of executive financial management experience in the pharmaceutical industry, in particular, in manufacturing, logistics an
Top Business Services Companies
Frequently Asked Questions Regarding Immuno Cure
Founded in 2015, Immuno Cure is a biotechnology company with a focus on the research and development of immunotherapies for cancers. The company is headquartered in Hong Kong, China.... Read More
